iRhythm Holdings, Inc. (IRTC) 8-K Current Report: March 12, 2026
Filed: March 12, 2026
Health Care
Surgical & Medical Instruments & ApparatusiRhythm Holdings, Inc. (IRTC) 8-K current report filed with SEC EDGAR on March 12, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items2 items
- Item 5.02: Departure/Election of Directors or Officers
- Item 7.01: Regulation FD Disclosure
iRhythm Holdings, Inc. 8-K Mar 12, 2026 Event Analysis
Item 5.02 · Departure/Election of Directors or Officers
- • Jason Patten appointed to Board and Audit Committee effective March 12, 2026; term expires at 2026 Annual Meeting
- • Initial RSU grant of $300,000 vesting annually over 3 years; accelerates fully upon change of control
- • Annual cash retainer of $65,000 total ($55,000 Board + $10,000 Audit Committee), paid quarterly
- • Prior to appointment, Patten served as advisor to CEO; received one-time cash payment of $86,771 for those services
- • Board determined Patten qualifies as independent director under Nasdaq standards and SEC Rule 10A-3
Item 7.01 · Regulation FD Disclosure
- • New board member appointed: Mr. Patten joins iRhythm (IRTC) Board of Directors
- • Board composition change can signal strategic shift in governance, oversight, or future M&A direction
- • Full details in Exhibit 99.1 press release attached to this 8-K filing
Get deeper insights on iRhythm Holdings, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.